Clinical Trial

Safety and Tolerability of EO2002

Name: Safety and Tolerability of EO2002 — clinical trial record (NCT05587205)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this clinical study is to assess the safety of intracameral injection of EO2002 in subjects post-cataract surgery.

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2022-10-17; most recent amendment 2025-12-02.

Trial Details

NCT Number	NCT05587205
Lead Sponsor	Asociación para Evitar la Ceguera en México Collaborators: Emmecell
Conditions	Cataract, Endothelial Cell Loss, Corneal
Enrollment	32 participants
Start Date	2022-08-30
Primary Completion	2026-10-06 (estimated)
Study Completion	2026-10-06 (estimated)
Updated on ClinicalTrials.gov	2025-12-08